Global Anti-helminthic Drugs Market Growth 2026-2032
The global Anti-helminthic Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Antihelmintics are a class of drugs used to treat parasitic infections caused by worms, including nematodes, tapeworms, flukes, etc. These drugs work by various mechanisms to kill or expel the parasites, helping to clear worm infections from the body. Helminths are parasites that can live in humans or animals and can cause a variety of diseases that affect the digestive system, respiratory system, blood system, etc.
United States market for Anti-helminthic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Anti-helminthic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Anti-helminthic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Anti-helminthic Drugs players cover GlaxoSmithKline, Sequent Scientific, K.A. Malle Pharmaceuticals, Lasa Supergenerics Limited, Fredun Pharmaceuticals Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Anti-helminthic Drugs Industry Forecast? looks at past sales and reviews total world Anti-helminthic Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Anti-helminthic Drugs sales for 2026 through 2032. With Anti-helminthic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-helminthic Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anti-helminthic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-helminthic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Anti-helminthic Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-helminthic Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-helminthic Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-helminthic Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Anti-helminthic Drugs market?
What factors are driving Anti-helminthic Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-helminthic Drugs market opportunities vary by end market size?
How does Anti-helminthic Drugs break out by Type, by Application?
Antihelmintics are a class of drugs used to treat parasitic infections caused by worms, including nematodes, tapeworms, flukes, etc. These drugs work by various mechanisms to kill or expel the parasites, helping to clear worm infections from the body. Helminths are parasites that can live in humans or animals and can cause a variety of diseases that affect the digestive system, respiratory system, blood system, etc.
United States market for Anti-helminthic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Anti-helminthic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Anti-helminthic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Anti-helminthic Drugs players cover GlaxoSmithKline, Sequent Scientific, K.A. Malle Pharmaceuticals, Lasa Supergenerics Limited, Fredun Pharmaceuticals Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Anti-helminthic Drugs Industry Forecast? looks at past sales and reviews total world Anti-helminthic Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Anti-helminthic Drugs sales for 2026 through 2032. With Anti-helminthic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-helminthic Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anti-helminthic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-helminthic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Anti-helminthic Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-helminthic Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-helminthic Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-helminthic Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Praziquantel
- Albendazole
- Mimbendazole
- Piperazine
- Pyrantel Pamoate
- For Veterinary Use
- For Human Use
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GlaxoSmithKline
- Sequent Scientific
- K.A. Malle Pharmaceuticals
- Lasa Supergenerics Limited
- Fredun Pharmaceuticals Ltd
- Salius Pharma
- Johnson & Johnson
- Amneal Pharmaceuticals
- Cadila Pharmaceuticals
- Eipico
- Esteve Pharmaceuticals
- Merck
- Shanghai Tengrui Pharmaceutical Co., Ltd.
- Shaanxi Hanwang Pharmaceutical Co., Ltd.
- Beijing Taiyang Pharmaceutical Co., Ltd.
- Guilin Nanyao Pharmaceutical Co., Ltd.
- Fujian Dongrui Pharmaceutical Co., Ltd.
- Jiaozuo Furuitang Pharmaceutical Co., Ltd.
- Shaoxing Minsheng Pharmaceutical Co., Ltd.
- Chengdu Hengda Pharmaceutical Co., Ltd.
- China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
- Diao Group Chengdu Pharmaceutical Co., Ltd.
- Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
- Anhui Shengying Pharmaceutical Co., Ltd.
- Sichuan Tiande Pharmaceutical Co., Ltd.
- Hubei Ruihua Pharmaceutical Co., Ltd.
- Zhejiang Anbet Pharmaceutical Co., Ltd.
- Nanjing Pharmaceutical Factory Co., Ltd.
- Zhejiang Hisun Pharmaceutical Co., Ltd.
- Southwest Pharmaceutical Co., Ltd.
What is the 10-year outlook for the global Anti-helminthic Drugs market?
What factors are driving Anti-helminthic Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-helminthic Drugs market opportunities vary by end market size?
How does Anti-helminthic Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-helminthic Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Anti-helminthic Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Anti-helminthic Drugs by Country/Region, 2021, 2025 & 2032
2.2 Anti-helminthic Drugs Segment by Type
2.2.1 Praziquantel
2.2.2 Albendazole
2.2.3 Mimbendazole
2.2.4 Piperazine
2.2.5 Pyrantel Pamoate
2.2.6 Anti-helminthic Drugs Sales by Type
2.2.6.1 Global Anti-helminthic Drugs Sales Market Share by Type (2021-2026)
2.2.6.2 Global Anti-helminthic Drugs Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Anti-helminthic Drugs Sale Price by Type (2021-2026)
2.3 Anti-helminthic Drugs Segment by Application
2.3.1 For Veterinary Use
2.3.2 For Human Use
2.3.3 Anti-helminthic Drugs Sales by Application
2.3.3.1 Global Anti-helminthic Drugs Sale Market Share by Application (2021-2026)
2.3.3.2 Global Anti-helminthic Drugs Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Anti-helminthic Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Anti-helminthic Drugs Breakdown Data by Company
3.1.1 Global Anti-helminthic Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Anti-helminthic Drugs Sales Market Share by Company (2021-2026)
3.2 Global Anti-helminthic Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Anti-helminthic Drugs Revenue by Company (2021-2026)
3.2.2 Global Anti-helminthic Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Anti-helminthic Drugs Sale Price by Company
3.4 Key Manufacturers Anti-helminthic Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-helminthic Drugs Product Location Distribution
3.4.2 Players Anti-helminthic Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-HELMINTHIC DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Anti-helminthic Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Anti-helminthic Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Anti-helminthic Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Anti-helminthic Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Anti-helminthic Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Anti-helminthic Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Anti-helminthic Drugs Sales Growth
4.4 APAC Anti-helminthic Drugs Sales Growth
4.5 Europe Anti-helminthic Drugs Sales Growth
4.6 Middle East & Africa Anti-helminthic Drugs Sales Growth
5 AMERICAS
5.1 Americas Anti-helminthic Drugs Sales by Country
5.1.1 Americas Anti-helminthic Drugs Sales by Country (2021-2026)
5.1.2 Americas Anti-helminthic Drugs Revenue by Country (2021-2026)
5.2 Americas Anti-helminthic Drugs Sales by Type (2021-2026)
5.3 Americas Anti-helminthic Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-helminthic Drugs Sales by Region
6.1.1 APAC Anti-helminthic Drugs Sales by Region (2021-2026)
6.1.2 APAC Anti-helminthic Drugs Revenue by Region (2021-2026)
6.2 APAC Anti-helminthic Drugs Sales by Type (2021-2026)
6.3 APAC Anti-helminthic Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-helminthic Drugs by Country
7.1.1 Europe Anti-helminthic Drugs Sales by Country (2021-2026)
7.1.2 Europe Anti-helminthic Drugs Revenue by Country (2021-2026)
7.2 Europe Anti-helminthic Drugs Sales by Type (2021-2026)
7.3 Europe Anti-helminthic Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-helminthic Drugs by Country
8.1.1 Middle East & Africa Anti-helminthic Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Anti-helminthic Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Anti-helminthic Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Anti-helminthic Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-helminthic Drugs
10.3 Manufacturing Process Analysis of Anti-helminthic Drugs
10.4 Industry Chain Structure of Anti-helminthic Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-helminthic Drugs Distributors
11.3 Anti-helminthic Drugs Customer
12 WORLD FORECAST REVIEW FOR ANTI-HELMINTHIC DRUGS BY GEOGRAPHIC REGION
12.1 Global Anti-helminthic Drugs Market Size Forecast by Region
12.1.1 Global Anti-helminthic Drugs Forecast by Region (2027-2032)
12.1.2 Global Anti-helminthic Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Anti-helminthic Drugs Forecast by Type (2027-2032)
12.7 Global Anti-helminthic Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Anti-helminthic Drugs Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Sequent Scientific
13.2.1 Sequent Scientific Company Information
13.2.2 Sequent Scientific Anti-helminthic Drugs Product Portfolios and Specifications
13.2.3 Sequent Scientific Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sequent Scientific Main Business Overview
13.2.5 Sequent Scientific Latest Developments
13.3 K.A. Malle Pharmaceuticals
13.3.1 K.A. Malle Pharmaceuticals Company Information
13.3.2 K.A. Malle Pharmaceuticals Anti-helminthic Drugs Product Portfolios and Specifications
13.3.3 K.A. Malle Pharmaceuticals Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 K.A. Malle Pharmaceuticals Main Business Overview
13.3.5 K.A. Malle Pharmaceuticals Latest Developments
13.4 Lasa Supergenerics Limited
13.4.1 Lasa Supergenerics Limited Company Information
13.4.2 Lasa Supergenerics Limited Anti-helminthic Drugs Product Portfolios and Specifications
13.4.3 Lasa Supergenerics Limited Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Lasa Supergenerics Limited Main Business Overview
13.4.5 Lasa Supergenerics Limited Latest Developments
13.5 Fredun Pharmaceuticals Ltd
13.5.1 Fredun Pharmaceuticals Ltd Company Information
13.5.2 Fredun Pharmaceuticals Ltd Anti-helminthic Drugs Product Portfolios and Specifications
13.5.3 Fredun Pharmaceuticals Ltd Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Fredun Pharmaceuticals Ltd Main Business Overview
13.5.5 Fredun Pharmaceuticals Ltd Latest Developments
13.6 Salius Pharma
13.6.1 Salius Pharma Company Information
13.6.2 Salius Pharma Anti-helminthic Drugs Product Portfolios and Specifications
13.6.3 Salius Pharma Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Salius Pharma Main Business Overview
13.6.5 Salius Pharma Latest Developments
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Information
13.7.2 Johnson & Johnson Anti-helminthic Drugs Product Portfolios and Specifications
13.7.3 Johnson & Johnson Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Johnson & Johnson Main Business Overview
13.7.5 Johnson & Johnson Latest Developments
13.8 Amneal Pharmaceuticals
13.8.1 Amneal Pharmaceuticals Company Information
13.8.2 Amneal Pharmaceuticals Anti-helminthic Drugs Product Portfolios and Specifications
13.8.3 Amneal Pharmaceuticals Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Amneal Pharmaceuticals Main Business Overview
13.8.5 Amneal Pharmaceuticals Latest Developments
13.9 Cadila Pharmaceuticals
13.9.1 Cadila Pharmaceuticals Company Information
13.9.2 Cadila Pharmaceuticals Anti-helminthic Drugs Product Portfolios and Specifications
13.9.3 Cadila Pharmaceuticals Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Cadila Pharmaceuticals Main Business Overview
13.9.5 Cadila Pharmaceuticals Latest Developments
13.10 Eipico
13.10.1 Eipico Company Information
13.10.2 Eipico Anti-helminthic Drugs Product Portfolios and Specifications
13.10.3 Eipico Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Eipico Main Business Overview
13.10.5 Eipico Latest Developments
13.11 Esteve Pharmaceuticals
13.11.1 Esteve Pharmaceuticals Company Information
13.11.2 Esteve Pharmaceuticals Anti-helminthic Drugs Product Portfolios and Specifications
13.11.3 Esteve Pharmaceuticals Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Esteve Pharmaceuticals Main Business Overview
13.11.5 Esteve Pharmaceuticals Latest Developments
13.12 Merck
13.12.1 Merck Company Information
13.12.2 Merck Anti-helminthic Drugs Product Portfolios and Specifications
13.12.3 Merck Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Merck Main Business Overview
13.12.5 Merck Latest Developments
13.13 Shanghai Tengrui Pharmaceutical Co., Ltd.
13.13.1 Shanghai Tengrui Pharmaceutical Co., Ltd. Company Information
13.13.2 Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.13.3 Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shanghai Tengrui Pharmaceutical Co., Ltd. Main Business Overview
13.13.5 Shanghai Tengrui Pharmaceutical Co., Ltd. Latest Developments
13.14 Shaanxi Hanwang Pharmaceutical Co., Ltd.
13.14.1 Shaanxi Hanwang Pharmaceutical Co., Ltd. Company Information
13.14.2 Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.14.3 Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Shaanxi Hanwang Pharmaceutical Co., Ltd. Main Business Overview
13.14.5 Shaanxi Hanwang Pharmaceutical Co., Ltd. Latest Developments
13.15 Beijing Taiyang Pharmaceutical Co., Ltd.
13.15.1 Beijing Taiyang Pharmaceutical Co., Ltd. Company Information
13.15.2 Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.15.3 Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Beijing Taiyang Pharmaceutical Co., Ltd. Main Business Overview
13.15.5 Beijing Taiyang Pharmaceutical Co., Ltd. Latest Developments
13.16 Guilin Nanyao Pharmaceutical Co., Ltd.
13.16.1 Guilin Nanyao Pharmaceutical Co., Ltd. Company Information
13.16.2 Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.16.3 Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Guilin Nanyao Pharmaceutical Co., Ltd. Main Business Overview
13.16.5 Guilin Nanyao Pharmaceutical Co., Ltd. Latest Developments
13.17 Fujian Dongrui Pharmaceutical Co., Ltd.
13.17.1 Fujian Dongrui Pharmaceutical Co., Ltd. Company Information
13.17.2 Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.17.3 Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Fujian Dongrui Pharmaceutical Co., Ltd. Main Business Overview
13.17.5 Fujian Dongrui Pharmaceutical Co., Ltd. Latest Developments
13.18 Jiaozuo Furuitang Pharmaceutical Co., Ltd.
13.18.1 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Company Information
13.18.2 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.18.3 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Main Business Overview
13.18.5 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Latest Developments
13.19 Shaoxing Minsheng Pharmaceutical Co., Ltd.
13.19.1 Shaoxing Minsheng Pharmaceutical Co., Ltd. Company Information
13.19.2 Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.19.3 Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Shaoxing Minsheng Pharmaceutical Co., Ltd. Main Business Overview
13.19.5 Shaoxing Minsheng Pharmaceutical Co., Ltd. Latest Developments
13.20 Chengdu Hengda Pharmaceutical Co., Ltd.
13.20.1 Chengdu Hengda Pharmaceutical Co., Ltd. Company Information
13.20.2 Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.20.3 Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Chengdu Hengda Pharmaceutical Co., Ltd. Main Business Overview
13.20.5 Chengdu Hengda Pharmaceutical Co., Ltd. Latest Developments
13.21 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
13.21.1 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information
13.21.2 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.21.3 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Main Business Overview
13.21.5 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Latest Developments
13.22 Diao Group Chengdu Pharmaceutical Co., Ltd.
13.22.1 Diao Group Chengdu Pharmaceutical Co., Ltd. Company Information
13.22.2 Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.22.3 Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Diao Group Chengdu Pharmaceutical Co., Ltd. Main Business Overview
13.22.5 Diao Group Chengdu Pharmaceutical Co., Ltd. Latest Developments
13.23 Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
13.23.1 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information
13.23.2 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.23.3 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Main Business Overview
13.23.5 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Latest Developments
13.24 Anhui Shengying Pharmaceutical Co., Ltd.
13.24.1 Anhui Shengying Pharmaceutical Co., Ltd. Company Information
13.24.2 Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.24.3 Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Anhui Shengying Pharmaceutical Co., Ltd. Main Business Overview
13.24.5 Anhui Shengying Pharmaceutical Co., Ltd. Latest Developments
13.25 Sichuan Tiande Pharmaceutical Co., Ltd.
13.25.1 Sichuan Tiande Pharmaceutical Co., Ltd. Company Information
13.25.2 Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.25.3 Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 Sichuan Tiande Pharmaceutical Co., Ltd. Main Business Overview
13.25.5 Sichuan Tiande Pharmaceutical Co., Ltd. Latest Developments
13.26 Hubei Ruihua Pharmaceutical Co., Ltd.
13.26.1 Hubei Ruihua Pharmaceutical Co., Ltd. Company Information
13.26.2 Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.26.3 Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 Hubei Ruihua Pharmaceutical Co., Ltd. Main Business Overview
13.26.5 Hubei Ruihua Pharmaceutical Co., Ltd. Latest Developments
13.27 Zhejiang Anbet Pharmaceutical Co., Ltd.
13.27.1 Zhejiang Anbet Pharmaceutical Co., Ltd. Company Information
13.27.2 Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.27.3 Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 Zhejiang Anbet Pharmaceutical Co., Ltd. Main Business Overview
13.27.5 Zhejiang Anbet Pharmaceutical Co., Ltd. Latest Developments
13.28 Nanjing Pharmaceutical Factory Co., Ltd.
13.28.1 Nanjing Pharmaceutical Factory Co., Ltd. Company Information
13.28.2 Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.28.3 Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.28.4 Nanjing Pharmaceutical Factory Co., Ltd. Main Business Overview
13.28.5 Nanjing Pharmaceutical Factory Co., Ltd. Latest Developments
13.29 Zhejiang Hisun Pharmaceutical Co., Ltd.
13.29.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
13.29.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.29.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.29.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Main Business Overview
13.29.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Latest Developments
13.30 Southwest Pharmaceutical Co., Ltd.
13.30.1 Southwest Pharmaceutical Co., Ltd. Company Information
13.30.2 Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.30.3 Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.30.4 Southwest Pharmaceutical Co., Ltd. Main Business Overview
13.30.5 Southwest Pharmaceutical Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-helminthic Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Anti-helminthic Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Anti-helminthic Drugs by Country/Region, 2021, 2025 & 2032
2.2 Anti-helminthic Drugs Segment by Type
2.2.1 Praziquantel
2.2.2 Albendazole
2.2.3 Mimbendazole
2.2.4 Piperazine
2.2.5 Pyrantel Pamoate
2.2.6 Anti-helminthic Drugs Sales by Type
2.2.6.1 Global Anti-helminthic Drugs Sales Market Share by Type (2021-2026)
2.2.6.2 Global Anti-helminthic Drugs Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Anti-helminthic Drugs Sale Price by Type (2021-2026)
2.3 Anti-helminthic Drugs Segment by Application
2.3.1 For Veterinary Use
2.3.2 For Human Use
2.3.3 Anti-helminthic Drugs Sales by Application
2.3.3.1 Global Anti-helminthic Drugs Sale Market Share by Application (2021-2026)
2.3.3.2 Global Anti-helminthic Drugs Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Anti-helminthic Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Anti-helminthic Drugs Breakdown Data by Company
3.1.1 Global Anti-helminthic Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Anti-helminthic Drugs Sales Market Share by Company (2021-2026)
3.2 Global Anti-helminthic Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Anti-helminthic Drugs Revenue by Company (2021-2026)
3.2.2 Global Anti-helminthic Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Anti-helminthic Drugs Sale Price by Company
3.4 Key Manufacturers Anti-helminthic Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-helminthic Drugs Product Location Distribution
3.4.2 Players Anti-helminthic Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-HELMINTHIC DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Anti-helminthic Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Anti-helminthic Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Anti-helminthic Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Anti-helminthic Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Anti-helminthic Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Anti-helminthic Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Anti-helminthic Drugs Sales Growth
4.4 APAC Anti-helminthic Drugs Sales Growth
4.5 Europe Anti-helminthic Drugs Sales Growth
4.6 Middle East & Africa Anti-helminthic Drugs Sales Growth
5 AMERICAS
5.1 Americas Anti-helminthic Drugs Sales by Country
5.1.1 Americas Anti-helminthic Drugs Sales by Country (2021-2026)
5.1.2 Americas Anti-helminthic Drugs Revenue by Country (2021-2026)
5.2 Americas Anti-helminthic Drugs Sales by Type (2021-2026)
5.3 Americas Anti-helminthic Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-helminthic Drugs Sales by Region
6.1.1 APAC Anti-helminthic Drugs Sales by Region (2021-2026)
6.1.2 APAC Anti-helminthic Drugs Revenue by Region (2021-2026)
6.2 APAC Anti-helminthic Drugs Sales by Type (2021-2026)
6.3 APAC Anti-helminthic Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-helminthic Drugs by Country
7.1.1 Europe Anti-helminthic Drugs Sales by Country (2021-2026)
7.1.2 Europe Anti-helminthic Drugs Revenue by Country (2021-2026)
7.2 Europe Anti-helminthic Drugs Sales by Type (2021-2026)
7.3 Europe Anti-helminthic Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-helminthic Drugs by Country
8.1.1 Middle East & Africa Anti-helminthic Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Anti-helminthic Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Anti-helminthic Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Anti-helminthic Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-helminthic Drugs
10.3 Manufacturing Process Analysis of Anti-helminthic Drugs
10.4 Industry Chain Structure of Anti-helminthic Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-helminthic Drugs Distributors
11.3 Anti-helminthic Drugs Customer
12 WORLD FORECAST REVIEW FOR ANTI-HELMINTHIC DRUGS BY GEOGRAPHIC REGION
12.1 Global Anti-helminthic Drugs Market Size Forecast by Region
12.1.1 Global Anti-helminthic Drugs Forecast by Region (2027-2032)
12.1.2 Global Anti-helminthic Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Anti-helminthic Drugs Forecast by Type (2027-2032)
12.7 Global Anti-helminthic Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Anti-helminthic Drugs Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Sequent Scientific
13.2.1 Sequent Scientific Company Information
13.2.2 Sequent Scientific Anti-helminthic Drugs Product Portfolios and Specifications
13.2.3 Sequent Scientific Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sequent Scientific Main Business Overview
13.2.5 Sequent Scientific Latest Developments
13.3 K.A. Malle Pharmaceuticals
13.3.1 K.A. Malle Pharmaceuticals Company Information
13.3.2 K.A. Malle Pharmaceuticals Anti-helminthic Drugs Product Portfolios and Specifications
13.3.3 K.A. Malle Pharmaceuticals Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 K.A. Malle Pharmaceuticals Main Business Overview
13.3.5 K.A. Malle Pharmaceuticals Latest Developments
13.4 Lasa Supergenerics Limited
13.4.1 Lasa Supergenerics Limited Company Information
13.4.2 Lasa Supergenerics Limited Anti-helminthic Drugs Product Portfolios and Specifications
13.4.3 Lasa Supergenerics Limited Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Lasa Supergenerics Limited Main Business Overview
13.4.5 Lasa Supergenerics Limited Latest Developments
13.5 Fredun Pharmaceuticals Ltd
13.5.1 Fredun Pharmaceuticals Ltd Company Information
13.5.2 Fredun Pharmaceuticals Ltd Anti-helminthic Drugs Product Portfolios and Specifications
13.5.3 Fredun Pharmaceuticals Ltd Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Fredun Pharmaceuticals Ltd Main Business Overview
13.5.5 Fredun Pharmaceuticals Ltd Latest Developments
13.6 Salius Pharma
13.6.1 Salius Pharma Company Information
13.6.2 Salius Pharma Anti-helminthic Drugs Product Portfolios and Specifications
13.6.3 Salius Pharma Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Salius Pharma Main Business Overview
13.6.5 Salius Pharma Latest Developments
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Information
13.7.2 Johnson & Johnson Anti-helminthic Drugs Product Portfolios and Specifications
13.7.3 Johnson & Johnson Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Johnson & Johnson Main Business Overview
13.7.5 Johnson & Johnson Latest Developments
13.8 Amneal Pharmaceuticals
13.8.1 Amneal Pharmaceuticals Company Information
13.8.2 Amneal Pharmaceuticals Anti-helminthic Drugs Product Portfolios and Specifications
13.8.3 Amneal Pharmaceuticals Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Amneal Pharmaceuticals Main Business Overview
13.8.5 Amneal Pharmaceuticals Latest Developments
13.9 Cadila Pharmaceuticals
13.9.1 Cadila Pharmaceuticals Company Information
13.9.2 Cadila Pharmaceuticals Anti-helminthic Drugs Product Portfolios and Specifications
13.9.3 Cadila Pharmaceuticals Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Cadila Pharmaceuticals Main Business Overview
13.9.5 Cadila Pharmaceuticals Latest Developments
13.10 Eipico
13.10.1 Eipico Company Information
13.10.2 Eipico Anti-helminthic Drugs Product Portfolios and Specifications
13.10.3 Eipico Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Eipico Main Business Overview
13.10.5 Eipico Latest Developments
13.11 Esteve Pharmaceuticals
13.11.1 Esteve Pharmaceuticals Company Information
13.11.2 Esteve Pharmaceuticals Anti-helminthic Drugs Product Portfolios and Specifications
13.11.3 Esteve Pharmaceuticals Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Esteve Pharmaceuticals Main Business Overview
13.11.5 Esteve Pharmaceuticals Latest Developments
13.12 Merck
13.12.1 Merck Company Information
13.12.2 Merck Anti-helminthic Drugs Product Portfolios and Specifications
13.12.3 Merck Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Merck Main Business Overview
13.12.5 Merck Latest Developments
13.13 Shanghai Tengrui Pharmaceutical Co., Ltd.
13.13.1 Shanghai Tengrui Pharmaceutical Co., Ltd. Company Information
13.13.2 Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.13.3 Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shanghai Tengrui Pharmaceutical Co., Ltd. Main Business Overview
13.13.5 Shanghai Tengrui Pharmaceutical Co., Ltd. Latest Developments
13.14 Shaanxi Hanwang Pharmaceutical Co., Ltd.
13.14.1 Shaanxi Hanwang Pharmaceutical Co., Ltd. Company Information
13.14.2 Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.14.3 Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Shaanxi Hanwang Pharmaceutical Co., Ltd. Main Business Overview
13.14.5 Shaanxi Hanwang Pharmaceutical Co., Ltd. Latest Developments
13.15 Beijing Taiyang Pharmaceutical Co., Ltd.
13.15.1 Beijing Taiyang Pharmaceutical Co., Ltd. Company Information
13.15.2 Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.15.3 Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Beijing Taiyang Pharmaceutical Co., Ltd. Main Business Overview
13.15.5 Beijing Taiyang Pharmaceutical Co., Ltd. Latest Developments
13.16 Guilin Nanyao Pharmaceutical Co., Ltd.
13.16.1 Guilin Nanyao Pharmaceutical Co., Ltd. Company Information
13.16.2 Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.16.3 Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Guilin Nanyao Pharmaceutical Co., Ltd. Main Business Overview
13.16.5 Guilin Nanyao Pharmaceutical Co., Ltd. Latest Developments
13.17 Fujian Dongrui Pharmaceutical Co., Ltd.
13.17.1 Fujian Dongrui Pharmaceutical Co., Ltd. Company Information
13.17.2 Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.17.3 Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Fujian Dongrui Pharmaceutical Co., Ltd. Main Business Overview
13.17.5 Fujian Dongrui Pharmaceutical Co., Ltd. Latest Developments
13.18 Jiaozuo Furuitang Pharmaceutical Co., Ltd.
13.18.1 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Company Information
13.18.2 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.18.3 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Main Business Overview
13.18.5 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Latest Developments
13.19 Shaoxing Minsheng Pharmaceutical Co., Ltd.
13.19.1 Shaoxing Minsheng Pharmaceutical Co., Ltd. Company Information
13.19.2 Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.19.3 Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Shaoxing Minsheng Pharmaceutical Co., Ltd. Main Business Overview
13.19.5 Shaoxing Minsheng Pharmaceutical Co., Ltd. Latest Developments
13.20 Chengdu Hengda Pharmaceutical Co., Ltd.
13.20.1 Chengdu Hengda Pharmaceutical Co., Ltd. Company Information
13.20.2 Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.20.3 Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Chengdu Hengda Pharmaceutical Co., Ltd. Main Business Overview
13.20.5 Chengdu Hengda Pharmaceutical Co., Ltd. Latest Developments
13.21 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
13.21.1 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information
13.21.2 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.21.3 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Main Business Overview
13.21.5 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Latest Developments
13.22 Diao Group Chengdu Pharmaceutical Co., Ltd.
13.22.1 Diao Group Chengdu Pharmaceutical Co., Ltd. Company Information
13.22.2 Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.22.3 Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Diao Group Chengdu Pharmaceutical Co., Ltd. Main Business Overview
13.22.5 Diao Group Chengdu Pharmaceutical Co., Ltd. Latest Developments
13.23 Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
13.23.1 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information
13.23.2 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.23.3 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Main Business Overview
13.23.5 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Latest Developments
13.24 Anhui Shengying Pharmaceutical Co., Ltd.
13.24.1 Anhui Shengying Pharmaceutical Co., Ltd. Company Information
13.24.2 Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.24.3 Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Anhui Shengying Pharmaceutical Co., Ltd. Main Business Overview
13.24.5 Anhui Shengying Pharmaceutical Co., Ltd. Latest Developments
13.25 Sichuan Tiande Pharmaceutical Co., Ltd.
13.25.1 Sichuan Tiande Pharmaceutical Co., Ltd. Company Information
13.25.2 Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.25.3 Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 Sichuan Tiande Pharmaceutical Co., Ltd. Main Business Overview
13.25.5 Sichuan Tiande Pharmaceutical Co., Ltd. Latest Developments
13.26 Hubei Ruihua Pharmaceutical Co., Ltd.
13.26.1 Hubei Ruihua Pharmaceutical Co., Ltd. Company Information
13.26.2 Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.26.3 Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 Hubei Ruihua Pharmaceutical Co., Ltd. Main Business Overview
13.26.5 Hubei Ruihua Pharmaceutical Co., Ltd. Latest Developments
13.27 Zhejiang Anbet Pharmaceutical Co., Ltd.
13.27.1 Zhejiang Anbet Pharmaceutical Co., Ltd. Company Information
13.27.2 Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.27.3 Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 Zhejiang Anbet Pharmaceutical Co., Ltd. Main Business Overview
13.27.5 Zhejiang Anbet Pharmaceutical Co., Ltd. Latest Developments
13.28 Nanjing Pharmaceutical Factory Co., Ltd.
13.28.1 Nanjing Pharmaceutical Factory Co., Ltd. Company Information
13.28.2 Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.28.3 Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.28.4 Nanjing Pharmaceutical Factory Co., Ltd. Main Business Overview
13.28.5 Nanjing Pharmaceutical Factory Co., Ltd. Latest Developments
13.29 Zhejiang Hisun Pharmaceutical Co., Ltd.
13.29.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
13.29.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.29.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.29.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Main Business Overview
13.29.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Latest Developments
13.30 Southwest Pharmaceutical Co., Ltd.
13.30.1 Southwest Pharmaceutical Co., Ltd. Company Information
13.30.2 Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
13.30.3 Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.30.4 Southwest Pharmaceutical Co., Ltd. Main Business Overview
13.30.5 Southwest Pharmaceutical Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Anti-helminthic Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Anti-helminthic Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Praziquantel
Table 4. Major Players of Albendazole
Table 5. Major Players of Mimbendazole
Table 6. Major Players of Piperazine
Table 7. Major Players of Pyrantel Pamoate
Table 8. Global Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units)
Table 9. Global Anti-helminthic Drugs Sales Market Share by Type (2021-2026)
Table 10. Global Anti-helminthic Drugs Revenue by Type (2021-2026) & ($ million)
Table 11. Global Anti-helminthic Drugs Revenue Market Share by Type (2021-2026)
Table 12. Global Anti-helminthic Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Anti-helminthic Drugs Sale by Application (2021-2026) & (K Units)
Table 14. Global Anti-helminthic Drugs Sale Market Share by Application (2021-2026)
Table 15. Global Anti-helminthic Drugs Revenue by Application (2021-2026) & ($ million)
Table 16. Global Anti-helminthic Drugs Revenue Market Share by Application (2021-2026)
Table 17. Global Anti-helminthic Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Anti-helminthic Drugs Sales by Company (2021-2026) & (K Units)
Table 19. Global Anti-helminthic Drugs Sales Market Share by Company (2021-2026)
Table 20. Global Anti-helminthic Drugs Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Anti-helminthic Drugs Revenue Market Share by Company (2021-2026)
Table 22. Global Anti-helminthic Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Anti-helminthic Drugs Producing Area Distribution and Sales Area
Table 24. Players Anti-helminthic Drugs Products Offered
Table 25. Anti-helminthic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Anti-helminthic Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Anti-helminthic Drugs Sales Market Share Geographic Region (2021-2026)
Table 30. Global Anti-helminthic Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Anti-helminthic Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Anti-helminthic Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Anti-helminthic Drugs Sales Market Share by Country/Region (2021-2026)
Table 34. Global Anti-helminthic Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Anti-helminthic Drugs Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units)
Table 37. Americas Anti-helminthic Drugs Sales Market Share by Country (2021-2026)
Table 38. Americas Anti-helminthic Drugs Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units)
Table 40. Americas Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units)
Table 41. APAC Anti-helminthic Drugs Sales by Region (2021-2026) & (K Units)
Table 42. APAC Anti-helminthic Drugs Sales Market Share by Region (2021-2026)
Table 43. APAC Anti-helminthic Drugs Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units)
Table 45. APAC Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units)
Table 46. Europe Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units)
Table 47. Europe Anti-helminthic Drugs Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units)
Table 49. Europe Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Anti-helminthic Drugs Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Anti-helminthic Drugs
Table 55. Key Market Challenges & Risks of Anti-helminthic Drugs
Table 56. Key Industry Trends of Anti-helminthic Drugs
Table 57. Anti-helminthic Drugs Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Anti-helminthic Drugs Distributors List
Table 60. Anti-helminthic Drugs Customer List
Table 61. Global Anti-helminthic Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Anti-helminthic Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Anti-helminthic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Anti-helminthic Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Anti-helminthic Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Anti-helminthic Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Anti-helminthic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Anti-helminthic Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Anti-helminthic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Anti-helminthic Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Anti-helminthic Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Anti-helminthic Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Anti-helminthic Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Anti-helminthic Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. GlaxoSmithKline Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 76. GlaxoSmithKline Anti-helminthic Drugs Product Portfolios and Specifications
Table 77. GlaxoSmithKline Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. GlaxoSmithKline Main Business
Table 79. GlaxoSmithKline Latest Developments
Table 80. Sequent Scientific Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Sequent Scientific Anti-helminthic Drugs Product Portfolios and Specifications
Table 82. Sequent Scientific Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Sequent Scientific Main Business
Table 84. Sequent Scientific Latest Developments
Table 85. K.A. Malle Pharmaceuticals Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. K.A. Malle Pharmaceuticals Anti-helminthic Drugs Product Portfolios and Specifications
Table 87. K.A. Malle Pharmaceuticals Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. K.A. Malle Pharmaceuticals Main Business
Table 89. K.A. Malle Pharmaceuticals Latest Developments
Table 90. Lasa Supergenerics Limited Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Lasa Supergenerics Limited Anti-helminthic Drugs Product Portfolios and Specifications
Table 92. Lasa Supergenerics Limited Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Lasa Supergenerics Limited Main Business
Table 94. Lasa Supergenerics Limited Latest Developments
Table 95. Fredun Pharmaceuticals Ltd Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Fredun Pharmaceuticals Ltd Anti-helminthic Drugs Product Portfolios and Specifications
Table 97. Fredun Pharmaceuticals Ltd Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Fredun Pharmaceuticals Ltd Main Business
Table 99. Fredun Pharmaceuticals Ltd Latest Developments
Table 100. Salius Pharma Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Salius Pharma Anti-helminthic Drugs Product Portfolios and Specifications
Table 102. Salius Pharma Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Salius Pharma Main Business
Table 104. Salius Pharma Latest Developments
Table 105. Johnson & Johnson Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Johnson & Johnson Anti-helminthic Drugs Product Portfolios and Specifications
Table 107. Johnson & Johnson Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Johnson & Johnson Main Business
Table 109. Johnson & Johnson Latest Developments
Table 110. Amneal Pharmaceuticals Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Amneal Pharmaceuticals Anti-helminthic Drugs Product Portfolios and Specifications
Table 112. Amneal Pharmaceuticals Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Amneal Pharmaceuticals Main Business
Table 114. Amneal Pharmaceuticals Latest Developments
Table 115. Cadila Pharmaceuticals Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Cadila Pharmaceuticals Anti-helminthic Drugs Product Portfolios and Specifications
Table 117. Cadila Pharmaceuticals Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Cadila Pharmaceuticals Main Business
Table 119. Cadila Pharmaceuticals Latest Developments
Table 120. Eipico Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Eipico Anti-helminthic Drugs Product Portfolios and Specifications
Table 122. Eipico Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Eipico Main Business
Table 124. Eipico Latest Developments
Table 125. Esteve Pharmaceuticals Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Esteve Pharmaceuticals Anti-helminthic Drugs Product Portfolios and Specifications
Table 127. Esteve Pharmaceuticals Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Esteve Pharmaceuticals Main Business
Table 129. Esteve Pharmaceuticals Latest Developments
Table 130. Merck Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Merck Anti-helminthic Drugs Product Portfolios and Specifications
Table 132. Merck Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Merck Main Business
Table 134. Merck Latest Developments
Table 135. Shanghai Tengrui Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 137. Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Shanghai Tengrui Pharmaceutical Co., Ltd. Main Business
Table 139. Shanghai Tengrui Pharmaceutical Co., Ltd. Latest Developments
Table 140. Shaanxi Hanwang Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 142. Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Shaanxi Hanwang Pharmaceutical Co., Ltd. Main Business
Table 144. Shaanxi Hanwang Pharmaceutical Co., Ltd. Latest Developments
Table 145. Beijing Taiyang Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 147. Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Beijing Taiyang Pharmaceutical Co., Ltd. Main Business
Table 149. Beijing Taiyang Pharmaceutical Co., Ltd. Latest Developments
Table 150. Guilin Nanyao Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 151. Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 152. Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Guilin Nanyao Pharmaceutical Co., Ltd. Main Business
Table 154. Guilin Nanyao Pharmaceutical Co., Ltd. Latest Developments
Table 155. Fujian Dongrui Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 156. Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 157. Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. Fujian Dongrui Pharmaceutical Co., Ltd. Main Business
Table 159. Fujian Dongrui Pharmaceutical Co., Ltd. Latest Developments
Table 160. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 161. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 162. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Main Business
Table 164. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Latest Developments
Table 165. Shaoxing Minsheng Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 166. Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 167. Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. Shaoxing Minsheng Pharmaceutical Co., Ltd. Main Business
Table 169. Shaoxing Minsheng Pharmaceutical Co., Ltd. Latest Developments
Table 170. Chengdu Hengda Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 171. Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 172. Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 173. Chengdu Hengda Pharmaceutical Co., Ltd. Main Business
Table 174. Chengdu Hengda Pharmaceutical Co., Ltd. Latest Developments
Table 175. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 176. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 177. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 178. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Main Business
Table 179. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Latest Developments
Table 180. Diao Group Chengdu Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 181. Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 182. Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 183. Diao Group Chengdu Pharmaceutical Co., Ltd. Main Business
Table 184. Diao Group Chengdu Pharmaceutical Co., Ltd. Latest Developments
Table 185. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 186. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 187. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 188. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Main Business
Table 189. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Latest Developments
Table 190. Anhui Shengying Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 191. Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 192. Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 193. Anhui Shengying Pharmaceutical Co., Ltd. Main Business
Table 194. Anhui Shengying Pharmaceutical Co., Ltd. Latest Developments
Table 195. Sichuan Tiande Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 196. Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 197. Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 198. Sichuan Tiande Pharmaceutical Co., Ltd. Main Business
Table 199. Sichuan Tiande Pharmaceutical Co., Ltd. Latest Developments
Table 200. Hubei Ruihua Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 201. Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 202. Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 203. Hubei Ruihua Pharmaceutical Co., Ltd. Main Business
Table 204. Hubei Ruihua Pharmaceutical Co., Ltd. Latest Developments
Table 205. Zhejiang Anbet Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 206. Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 207. Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 208. Zhejiang Anbet Pharmaceutical Co., Ltd. Main Business
Table 209. Zhejiang Anbet Pharmaceutical Co., Ltd. Latest Developments
Table 210. Nanjing Pharmaceutical Factory Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 211. Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 212. Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 213. Nanjing Pharmaceutical Factory Co., Ltd. Main Business
Table 214. Nanjing Pharmaceutical Factory Co., Ltd. Latest Developments
Table 215. Zhejiang Hisun Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 216. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 217. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 218. Zhejiang Hisun Pharmaceutical Co., Ltd. Main Business
Table 219. Zhejiang Hisun Pharmaceutical Co., Ltd. Latest Developments
Table 220. Southwest Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 221. Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 222. Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 223. Southwest Pharmaceutical Co., Ltd. Main Business
Table 224. Southwest Pharmaceutical Co., Ltd. Latest Developments
Table 1. Anti-helminthic Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Anti-helminthic Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Praziquantel
Table 4. Major Players of Albendazole
Table 5. Major Players of Mimbendazole
Table 6. Major Players of Piperazine
Table 7. Major Players of Pyrantel Pamoate
Table 8. Global Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units)
Table 9. Global Anti-helminthic Drugs Sales Market Share by Type (2021-2026)
Table 10. Global Anti-helminthic Drugs Revenue by Type (2021-2026) & ($ million)
Table 11. Global Anti-helminthic Drugs Revenue Market Share by Type (2021-2026)
Table 12. Global Anti-helminthic Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Anti-helminthic Drugs Sale by Application (2021-2026) & (K Units)
Table 14. Global Anti-helminthic Drugs Sale Market Share by Application (2021-2026)
Table 15. Global Anti-helminthic Drugs Revenue by Application (2021-2026) & ($ million)
Table 16. Global Anti-helminthic Drugs Revenue Market Share by Application (2021-2026)
Table 17. Global Anti-helminthic Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Anti-helminthic Drugs Sales by Company (2021-2026) & (K Units)
Table 19. Global Anti-helminthic Drugs Sales Market Share by Company (2021-2026)
Table 20. Global Anti-helminthic Drugs Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Anti-helminthic Drugs Revenue Market Share by Company (2021-2026)
Table 22. Global Anti-helminthic Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Anti-helminthic Drugs Producing Area Distribution and Sales Area
Table 24. Players Anti-helminthic Drugs Products Offered
Table 25. Anti-helminthic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Anti-helminthic Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Anti-helminthic Drugs Sales Market Share Geographic Region (2021-2026)
Table 30. Global Anti-helminthic Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Anti-helminthic Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Anti-helminthic Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Anti-helminthic Drugs Sales Market Share by Country/Region (2021-2026)
Table 34. Global Anti-helminthic Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Anti-helminthic Drugs Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units)
Table 37. Americas Anti-helminthic Drugs Sales Market Share by Country (2021-2026)
Table 38. Americas Anti-helminthic Drugs Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units)
Table 40. Americas Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units)
Table 41. APAC Anti-helminthic Drugs Sales by Region (2021-2026) & (K Units)
Table 42. APAC Anti-helminthic Drugs Sales Market Share by Region (2021-2026)
Table 43. APAC Anti-helminthic Drugs Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units)
Table 45. APAC Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units)
Table 46. Europe Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units)
Table 47. Europe Anti-helminthic Drugs Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units)
Table 49. Europe Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Anti-helminthic Drugs Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Anti-helminthic Drugs
Table 55. Key Market Challenges & Risks of Anti-helminthic Drugs
Table 56. Key Industry Trends of Anti-helminthic Drugs
Table 57. Anti-helminthic Drugs Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Anti-helminthic Drugs Distributors List
Table 60. Anti-helminthic Drugs Customer List
Table 61. Global Anti-helminthic Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Anti-helminthic Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Anti-helminthic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Anti-helminthic Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Anti-helminthic Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Anti-helminthic Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Anti-helminthic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Anti-helminthic Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Anti-helminthic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Anti-helminthic Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Anti-helminthic Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Anti-helminthic Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Anti-helminthic Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Anti-helminthic Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. GlaxoSmithKline Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 76. GlaxoSmithKline Anti-helminthic Drugs Product Portfolios and Specifications
Table 77. GlaxoSmithKline Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. GlaxoSmithKline Main Business
Table 79. GlaxoSmithKline Latest Developments
Table 80. Sequent Scientific Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Sequent Scientific Anti-helminthic Drugs Product Portfolios and Specifications
Table 82. Sequent Scientific Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Sequent Scientific Main Business
Table 84. Sequent Scientific Latest Developments
Table 85. K.A. Malle Pharmaceuticals Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. K.A. Malle Pharmaceuticals Anti-helminthic Drugs Product Portfolios and Specifications
Table 87. K.A. Malle Pharmaceuticals Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. K.A. Malle Pharmaceuticals Main Business
Table 89. K.A. Malle Pharmaceuticals Latest Developments
Table 90. Lasa Supergenerics Limited Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Lasa Supergenerics Limited Anti-helminthic Drugs Product Portfolios and Specifications
Table 92. Lasa Supergenerics Limited Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Lasa Supergenerics Limited Main Business
Table 94. Lasa Supergenerics Limited Latest Developments
Table 95. Fredun Pharmaceuticals Ltd Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Fredun Pharmaceuticals Ltd Anti-helminthic Drugs Product Portfolios and Specifications
Table 97. Fredun Pharmaceuticals Ltd Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Fredun Pharmaceuticals Ltd Main Business
Table 99. Fredun Pharmaceuticals Ltd Latest Developments
Table 100. Salius Pharma Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Salius Pharma Anti-helminthic Drugs Product Portfolios and Specifications
Table 102. Salius Pharma Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Salius Pharma Main Business
Table 104. Salius Pharma Latest Developments
Table 105. Johnson & Johnson Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Johnson & Johnson Anti-helminthic Drugs Product Portfolios and Specifications
Table 107. Johnson & Johnson Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Johnson & Johnson Main Business
Table 109. Johnson & Johnson Latest Developments
Table 110. Amneal Pharmaceuticals Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Amneal Pharmaceuticals Anti-helminthic Drugs Product Portfolios and Specifications
Table 112. Amneal Pharmaceuticals Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Amneal Pharmaceuticals Main Business
Table 114. Amneal Pharmaceuticals Latest Developments
Table 115. Cadila Pharmaceuticals Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Cadila Pharmaceuticals Anti-helminthic Drugs Product Portfolios and Specifications
Table 117. Cadila Pharmaceuticals Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Cadila Pharmaceuticals Main Business
Table 119. Cadila Pharmaceuticals Latest Developments
Table 120. Eipico Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Eipico Anti-helminthic Drugs Product Portfolios and Specifications
Table 122. Eipico Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Eipico Main Business
Table 124. Eipico Latest Developments
Table 125. Esteve Pharmaceuticals Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Esteve Pharmaceuticals Anti-helminthic Drugs Product Portfolios and Specifications
Table 127. Esteve Pharmaceuticals Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Esteve Pharmaceuticals Main Business
Table 129. Esteve Pharmaceuticals Latest Developments
Table 130. Merck Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Merck Anti-helminthic Drugs Product Portfolios and Specifications
Table 132. Merck Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Merck Main Business
Table 134. Merck Latest Developments
Table 135. Shanghai Tengrui Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 137. Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Shanghai Tengrui Pharmaceutical Co., Ltd. Main Business
Table 139. Shanghai Tengrui Pharmaceutical Co., Ltd. Latest Developments
Table 140. Shaanxi Hanwang Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 142. Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Shaanxi Hanwang Pharmaceutical Co., Ltd. Main Business
Table 144. Shaanxi Hanwang Pharmaceutical Co., Ltd. Latest Developments
Table 145. Beijing Taiyang Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 147. Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Beijing Taiyang Pharmaceutical Co., Ltd. Main Business
Table 149. Beijing Taiyang Pharmaceutical Co., Ltd. Latest Developments
Table 150. Guilin Nanyao Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 151. Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 152. Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Guilin Nanyao Pharmaceutical Co., Ltd. Main Business
Table 154. Guilin Nanyao Pharmaceutical Co., Ltd. Latest Developments
Table 155. Fujian Dongrui Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 156. Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 157. Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. Fujian Dongrui Pharmaceutical Co., Ltd. Main Business
Table 159. Fujian Dongrui Pharmaceutical Co., Ltd. Latest Developments
Table 160. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 161. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 162. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Main Business
Table 164. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Latest Developments
Table 165. Shaoxing Minsheng Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 166. Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 167. Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. Shaoxing Minsheng Pharmaceutical Co., Ltd. Main Business
Table 169. Shaoxing Minsheng Pharmaceutical Co., Ltd. Latest Developments
Table 170. Chengdu Hengda Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 171. Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 172. Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 173. Chengdu Hengda Pharmaceutical Co., Ltd. Main Business
Table 174. Chengdu Hengda Pharmaceutical Co., Ltd. Latest Developments
Table 175. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 176. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 177. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 178. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Main Business
Table 179. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Latest Developments
Table 180. Diao Group Chengdu Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 181. Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 182. Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 183. Diao Group Chengdu Pharmaceutical Co., Ltd. Main Business
Table 184. Diao Group Chengdu Pharmaceutical Co., Ltd. Latest Developments
Table 185. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 186. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 187. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 188. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Main Business
Table 189. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Latest Developments
Table 190. Anhui Shengying Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 191. Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 192. Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 193. Anhui Shengying Pharmaceutical Co., Ltd. Main Business
Table 194. Anhui Shengying Pharmaceutical Co., Ltd. Latest Developments
Table 195. Sichuan Tiande Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 196. Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 197. Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 198. Sichuan Tiande Pharmaceutical Co., Ltd. Main Business
Table 199. Sichuan Tiande Pharmaceutical Co., Ltd. Latest Developments
Table 200. Hubei Ruihua Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 201. Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 202. Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 203. Hubei Ruihua Pharmaceutical Co., Ltd. Main Business
Table 204. Hubei Ruihua Pharmaceutical Co., Ltd. Latest Developments
Table 205. Zhejiang Anbet Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 206. Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 207. Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 208. Zhejiang Anbet Pharmaceutical Co., Ltd. Main Business
Table 209. Zhejiang Anbet Pharmaceutical Co., Ltd. Latest Developments
Table 210. Nanjing Pharmaceutical Factory Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 211. Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 212. Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 213. Nanjing Pharmaceutical Factory Co., Ltd. Main Business
Table 214. Nanjing Pharmaceutical Factory Co., Ltd. Latest Developments
Table 215. Zhejiang Hisun Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 216. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 217. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 218. Zhejiang Hisun Pharmaceutical Co., Ltd. Main Business
Table 219. Zhejiang Hisun Pharmaceutical Co., Ltd. Latest Developments
Table 220. Southwest Pharmaceutical Co., Ltd. Basic Information, Anti-helminthic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 221. Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolios and Specifications
Table 222. Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 223. Southwest Pharmaceutical Co., Ltd. Main Business
Table 224. Southwest Pharmaceutical Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Anti-helminthic Drugs
Figure 2. Anti-helminthic Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-helminthic Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Anti-helminthic Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Anti-helminthic Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Anti-helminthic Drugs Sales Market Share by Country/Region (2025)
Figure 10. Anti-helminthic Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Praziquantel
Figure 12. Product Picture of Albendazole
Figure 13. Product Picture of Mimbendazole
Figure 14. Product Picture of Piperazine
Figure 15. Product Picture of Pyrantel Pamoate
Figure 16. Global Anti-helminthic Drugs Sales Market Share by Type in 2026
Figure 17. Global Anti-helminthic Drugs Revenue Market Share by Type (2021-2026)
Figure 18. Anti-helminthic Drugs Consumed in For Veterinary Use
Figure 19. Global Anti-helminthic Drugs Market: For Veterinary Use (2021-2026) & (K Units)
Figure 20. Anti-helminthic Drugs Consumed in For Human Use
Figure 21. Global Anti-helminthic Drugs Market: For Human Use (2021-2026) & (K Units)
Figure 22. Global Anti-helminthic Drugs Sale Market Share by Application (2025)
Figure 23. Global Anti-helminthic Drugs Revenue Market Share by Application in 2026
Figure 24. Anti-helminthic Drugs Sales by Company in 2026 (K Units)
Figure 25. Global Anti-helminthic Drugs Sales Market Share by Company in 2026
Figure 26. Anti-helminthic Drugs Revenue by Company in 2026 ($ millions)
Figure 27. Global Anti-helminthic Drugs Revenue Market Share by Company in 2026
Figure 28. Global Anti-helminthic Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Anti-helminthic Drugs Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Anti-helminthic Drugs Sales 2021-2026 (K Units)
Figure 31. Americas Anti-helminthic Drugs Revenue 2021-2026 ($ millions)
Figure 32. APAC Anti-helminthic Drugs Sales 2021-2026 (K Units)
Figure 33. APAC Anti-helminthic Drugs Revenue 2021-2026 ($ millions)
Figure 34. Europe Anti-helminthic Drugs Sales 2021-2026 (K Units)
Figure 35. Europe Anti-helminthic Drugs Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Anti-helminthic Drugs Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Anti-helminthic Drugs Revenue 2021-2026 ($ millions)
Figure 38. Americas Anti-helminthic Drugs Sales Market Share by Country in 2026
Figure 39. Americas Anti-helminthic Drugs Revenue Market Share by Country (2021-2026)
Figure 40. Americas Anti-helminthic Drugs Sales Market Share by Type (2021-2026)
Figure 41. Americas Anti-helminthic Drugs Sales Market Share by Application (2021-2026)
Figure 42. United States Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Anti-helminthic Drugs Sales Market Share by Region in 2026
Figure 47. APAC Anti-helminthic Drugs Revenue Market Share by Region (2021-2026)
Figure 48. APAC Anti-helminthic Drugs Sales Market Share by Type (2021-2026)
Figure 49. APAC Anti-helminthic Drugs Sales Market Share by Application (2021-2026)
Figure 50. China Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. India Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Anti-helminthic Drugs Sales Market Share by Country in 2026
Figure 58. Europe Anti-helminthic Drugs Revenue Market Share by Country (2021-2026)
Figure 59. Europe Anti-helminthic Drugs Sales Market Share by Type (2021-2026)
Figure 60. Europe Anti-helminthic Drugs Sales Market Share by Application (2021-2026)
Figure 61. Germany Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. France Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Anti-helminthic Drugs Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Anti-helminthic Drugs Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Anti-helminthic Drugs Sales Market Share by Application (2021-2026)
Figure 69. Egypt Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Anti-helminthic Drugs in 2026
Figure 75. Manufacturing Process Analysis of Anti-helminthic Drugs
Figure 76. Industry Chain Structure of Anti-helminthic Drugs
Figure 77. Channels of Distribution
Figure 78. Global Anti-helminthic Drugs Sales Market Forecast by Region (2027-2032)
Figure 79. Global Anti-helminthic Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Anti-helminthic Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Anti-helminthic Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Anti-helminthic Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Anti-helminthic Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Anti-helminthic Drugs
Figure 2. Anti-helminthic Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-helminthic Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Anti-helminthic Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Anti-helminthic Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Anti-helminthic Drugs Sales Market Share by Country/Region (2025)
Figure 10. Anti-helminthic Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Praziquantel
Figure 12. Product Picture of Albendazole
Figure 13. Product Picture of Mimbendazole
Figure 14. Product Picture of Piperazine
Figure 15. Product Picture of Pyrantel Pamoate
Figure 16. Global Anti-helminthic Drugs Sales Market Share by Type in 2026
Figure 17. Global Anti-helminthic Drugs Revenue Market Share by Type (2021-2026)
Figure 18. Anti-helminthic Drugs Consumed in For Veterinary Use
Figure 19. Global Anti-helminthic Drugs Market: For Veterinary Use (2021-2026) & (K Units)
Figure 20. Anti-helminthic Drugs Consumed in For Human Use
Figure 21. Global Anti-helminthic Drugs Market: For Human Use (2021-2026) & (K Units)
Figure 22. Global Anti-helminthic Drugs Sale Market Share by Application (2025)
Figure 23. Global Anti-helminthic Drugs Revenue Market Share by Application in 2026
Figure 24. Anti-helminthic Drugs Sales by Company in 2026 (K Units)
Figure 25. Global Anti-helminthic Drugs Sales Market Share by Company in 2026
Figure 26. Anti-helminthic Drugs Revenue by Company in 2026 ($ millions)
Figure 27. Global Anti-helminthic Drugs Revenue Market Share by Company in 2026
Figure 28. Global Anti-helminthic Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Anti-helminthic Drugs Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Anti-helminthic Drugs Sales 2021-2026 (K Units)
Figure 31. Americas Anti-helminthic Drugs Revenue 2021-2026 ($ millions)
Figure 32. APAC Anti-helminthic Drugs Sales 2021-2026 (K Units)
Figure 33. APAC Anti-helminthic Drugs Revenue 2021-2026 ($ millions)
Figure 34. Europe Anti-helminthic Drugs Sales 2021-2026 (K Units)
Figure 35. Europe Anti-helminthic Drugs Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Anti-helminthic Drugs Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Anti-helminthic Drugs Revenue 2021-2026 ($ millions)
Figure 38. Americas Anti-helminthic Drugs Sales Market Share by Country in 2026
Figure 39. Americas Anti-helminthic Drugs Revenue Market Share by Country (2021-2026)
Figure 40. Americas Anti-helminthic Drugs Sales Market Share by Type (2021-2026)
Figure 41. Americas Anti-helminthic Drugs Sales Market Share by Application (2021-2026)
Figure 42. United States Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Anti-helminthic Drugs Sales Market Share by Region in 2026
Figure 47. APAC Anti-helminthic Drugs Revenue Market Share by Region (2021-2026)
Figure 48. APAC Anti-helminthic Drugs Sales Market Share by Type (2021-2026)
Figure 49. APAC Anti-helminthic Drugs Sales Market Share by Application (2021-2026)
Figure 50. China Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. India Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Anti-helminthic Drugs Sales Market Share by Country in 2026
Figure 58. Europe Anti-helminthic Drugs Revenue Market Share by Country (2021-2026)
Figure 59. Europe Anti-helminthic Drugs Sales Market Share by Type (2021-2026)
Figure 60. Europe Anti-helminthic Drugs Sales Market Share by Application (2021-2026)
Figure 61. Germany Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. France Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Anti-helminthic Drugs Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Anti-helminthic Drugs Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Anti-helminthic Drugs Sales Market Share by Application (2021-2026)
Figure 69. Egypt Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Anti-helminthic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Anti-helminthic Drugs in 2026
Figure 75. Manufacturing Process Analysis of Anti-helminthic Drugs
Figure 76. Industry Chain Structure of Anti-helminthic Drugs
Figure 77. Channels of Distribution
Figure 78. Global Anti-helminthic Drugs Sales Market Forecast by Region (2027-2032)
Figure 79. Global Anti-helminthic Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Anti-helminthic Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Anti-helminthic Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Anti-helminthic Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Anti-helminthic Drugs Revenue Market Share Forecast by Application (2027-2032)
